Table 2 The relationship between the presence of a preoperative systemic inflammatory response and tumour characteristics of ductal adenocarcinoma of the head of the pancreas
C-reactive protein ⩽10 mg l−1 (n =32) | C-reactive protein>10 mg l−1 (n =33) | P -value | |
|---|---|---|---|
Age ⩽65/>65 years) | 15/17 | 22/11 | 0.107 |
Sex (f/m) | 21/11 | 12/21 | 0.018 |
Stage (I/II/III) | 9/2/21 | 8/0/25 | 0.302 |
Resection margin R0/R1 | 11/21 | 8/25 | 0.369 |
Tumour size (⩽25/>25 mm) | 18/14 | 9/24 | 0.018 |
Lymph node invasion (−/+) | 12/20 | 8/25 | 0.247 |
Perineural invasion (−/+) | 4/28 | 2/31 | 0.370 |
Vascular invasion (−/+) | 24/8 | 15/18 | 0.015 |
Tumour differentiation (well/moderate/poor) | 6/21/5 | 2/15/16 | 0.013 |
Albumin (⩾35/<35 g l−1) | 23/9 | 17/16 | 0.092 |
Bilirubin (⩽22/>22) | 26/6 | 27/6 | 0.953 |
Biliary stent (no/yes) | 18/14 | 14/19 | 0.265 |
Postoperative | |||
C-reactive protein (⩽10/>10 mg l−1) | 17/15 | 10/23 | 0.062 |
Survival (months)a | 18.2 (14.9–21.4) | 8.3 (6.6–10.0) | <0.001 |
